Fecal calgranulin C in patients with inflammatory bowel disease
Original articleGastroent Hepatol 2014; 68(1): 10-13.
Summarypdf Karin Malíčková, Martin Bortlík, Dana Ďuricová, Martin Lukáš, Luděk Hrdlička, Naděžda Machková, Milan LukášInfliximab does not increase the risk of early postoperative complications in UC patients after a three-stage restorative proctocolectomy with IPAA
Original articleGastroent Hepatol 2014; 68(1): 14-18.
Summarypdf Marta Kostrejová, Martin Bortlík, Milan Lukáš, Dana Ďuricová, Robert Mudr, Arnošt Komárek, Richard SequensFerric carboxymaltose: a highly effective and safe treatment of iron deficiency
Drug profileGastroent Hepatol 2014; 68(1): 85-87.
pdf Martin Bortlík9th Congress of ECCO, Copenhagen, Denmark
Congress reportGastroent Hepatol 2014; 68(2): 176.
pdf Martin BortlíkGolimumab – new biologic for therapy of ulcerative colitis
Congress reportGastroent Hepatol 2014; 68(3): 270-272.
pdf Martin BortlíkVedolizumab – a novel anti-integrin antibody with high gastrointestinal selectivity
Review articleGastroent Hepatol 2014; 68(6): 481–484. doi:10.14735/amgh2014481
SummaryLiteraturepdf Martin BortlíkNot only anti-TNF for IBD patients
EditorialGastroent Hepatol 2015; 69(1): 9–10.
Literaturepdf Martin BortlíkTherapy of inflammatory bowel diseases over the past two decades
Comment to the History and development of the branchGastroent Hepatol 2015; 69(4): 341–350.
SummaryLiteraturepdf Martin BortlíkRecommendation of surgical treatment in patients with inflammatory bowel diseases – part 2: Crohn̕s disease
GuidelinesGastroent Hepatol 2015; 69(3): 223–238. doi:10.14735/amgh2015223
SummaryLiteraturepdf Zuzana Šerclová, Ondřej Ryska, Martin Bortlík, Dana Ďuricová, Robert Gürlich, Pavel Lisý, Július Örhalmi, Pavel Kohout, Lucie Prokopová, Tomáš Douda, Pavel Drastich, Aleš Novotný, Petra Matějková, Karel Mareš, Olga Shonová, Luděk Hrdlička, Jana Koželuhová, Jiří Stehlík, Mojmír Kasalický, Jaroslav Kalvach, Jiří Bronský, Marie Tomanová, Martin Liberda, Přemysl Falt, Milan Lukáš, Vladimír ZbořilImmunoablative therapy and autologous hematopoietic stem cell transplantation in a patient with aggressive Crohn’s disease refractory to medical therapy
Review articleGastroent Hepatol 2015; 69(1): 50–54. doi: doi: 10.14735/amgh201550
SummaryLiteraturepdf Veronika Hrubá, Dana Ďuricová, Šárka Rahmatová, Naděžda Machková, Martin Bortlík, Martin Lukáš, Milan Lukáš, Katarína Mitrová, Martin Horák, Tomáš Kozák, Jan Novák